Cite
Zheng W, Feng Q, Liu J, et al. Inhibition of 6-phosphogluconate Dehydrogenase Reverses Cisplatin Resistance in Ovarian and Lung Cancer. Front Pharmacol. 2017;8:421doi: 10.3389/fphar.2017.00421.
Zheng, W., Feng, Q., Liu, J., Guo, Y., Gao, L., Li, R., Xu, M., Yan, G., Yin, Z., Zhang, S., Liu, S., & Shan, C. (2017). Inhibition of 6-phosphogluconate Dehydrogenase Reverses Cisplatin Resistance in Ovarian and Lung Cancer. Frontiers in pharmacology, 8421. https://doi.org/10.3389/fphar.2017.00421
Zheng, Wujian, et al. "Inhibition of 6-phosphogluconate Dehydrogenase Reverses Cisplatin Resistance in Ovarian and Lung Cancer." Frontiers in pharmacology vol. 8 (2017): 421. doi: https://doi.org/10.3389/fphar.2017.00421
Zheng W, Feng Q, Liu J, Guo Y, Gao L, Li R, Xu M, Yan G, Yin Z, Zhang S, Liu S, Shan C. Inhibition of 6-phosphogluconate Dehydrogenase Reverses Cisplatin Resistance in Ovarian and Lung Cancer. Front Pharmacol. 2017 Jun 30;8:421. doi: 10.3389/fphar.2017.00421. eCollection 2017. PMID: 28713273; PMCID: PMC5491617.
Copy
Download .nbib